The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Treatment of Schizophrenia
Open accessAbstract
Antipsychotic medication remains a mainstay of treatment in both acute and chronic schizophrenia. Emphasis in recent years has focused on maximizing benefits and minimizing risks of medication by attempting to establish minimum effective dosage requirements for all phases of treatment and to provide alternative strategies for individuals who fail to benefit from antipsychotic drug treatment. At present all approaches to the treatment-refractory patient remain experimental, and further research in this area is of critical importance. Definite advances have been made in exploring the impact of psychological and psychosocial treatments administered in conjunction with various antipsychotic drug strategies. More sophisticated and comprehensive assessment measures have been applied in long-term treatment trials, enabling us to be more specific about treatment goals and treatment evaluation. Although no major "breakthrough" has occurred in the treatment of schizophrenia, incremental advances which can reduce rates of relapse and rehospitalization, improve the quality of adaptation, and reduce the risk of significant adverse effects are of enormous importance to affected individuals, their families, and society at large.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Comparative Studies of Psychotherapies: Is It True That "Everyone Has Won and All Must Have Prizes"?
Luborsky, L. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760260059004 · Cited by 1,485
DISEASES OF THE NERVOUS SYSTEM
JELLIFFE, S. E., & WHITE, W. A. (1918) · The American Journal of the Medical Sciences · doi:10.1097/00000441-191803000-00015 · Cited by 1,277
Psychopharmacology : a generation of progress
Lipton, M. A., DiMascio, A., & Killam, K. F. (1978) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,212
Hogarty, G. E. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070019003 · Cited by 917
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.6.727 · Cited by 854
A Survey of Drug-Induced Extrapyramidal Reactions
Ayd, F. J. (1961) · JAMA · doi:10.1001/jama.1961.03040120016004 · Cited by 753
Tardive Dyskinesia: Prevalence and Risk Factors, 1959 to 1979
Kane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290040069010 · Cited by 656
Self-citationDrug and Sociotherapy in the Aftercare of Schizophrenic Patients: II. Two-Year Relapse Rates
Hogarty, G. E. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760170005001 · Cited by 573
Why Do Schizophrenic Patients Refuse to Take Their Drugs?
Van Putten, T. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760130049008 · Cited by 572
Cited by
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.457 · Cited by 891
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
Lehman, A. F., Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., Dixon, L. B., Goldberg, R., Green-Paden, L. D., Tenhula, W. N., Boerescu, D., Tek, C., et al. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007071 · Cited by 757
Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.
Spohn, H. E., & Strauss, M. E. (1989) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.98.4.367 · Cited by 381
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
Brissos, S., Veguilla, M. R., Taylor, D., & Balanzá-Martinez, V. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314540297 · Cited by 297
Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs
Ananth, J., Parameswaran, S., Gunatilake, S., Burgoyne, K., & Sidhom, T. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0403 · Cited by 273
Metadata
- Authors
- Kane, J. M.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 1987-01-01
- Volume
- 13
- Issue
- 1
- Pages
- 133-156
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2150727954
- Cited by
- 323
- References
- 93
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Schizophrenia. https://app.cochat.ai/papers/10.1093/schbul/13.1.133
- The paper
- Kane, J. M. (1987). Treatment of Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/13.1.133
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.